ENTITY

Halozyme Therapeutics (HALO US)

12
Analysis
Health CareUnited States
Halozyme Therapeutics, Inc. is a biopharmaceutical company developing products for the diabetes, cancer, dermatology and drug delivery markets. The Company's platform technology is based on recombinant human hyaluronidase plus additional enzymes. Halozyme applies its technology to its proprietary programs and to partnerships with pharmaceutical companies.
more
Company Event21 Feb 2025 05:00 • Upcoming
Add To Calendar
Company Event01 Nov 2024 04:30 • Latest
Company Event07 Aug 2024 04:30
x